Christopher W. Krueger, Chief Business Officer at Ventyx Biosciences, Inc. (VTYX), sold 30,000 shares at $38.94 ($1.2M) on 2023-05-03, disclosed to the SEC on 2023-05-04.
Open-market sale of $1.2M VTYX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.18 | 5,754 | $220K | 18.9% |
| 2 | $38.18 | 5,754 | $220K | 18.9% |
| 3 | $38.94 | 9,246 | $360K | 31.1% |
| 4 | $38.94 | 9,246 | $360K | 31.1% |
| Total | $38.65 avg | 30,000 | $1.2M | 100% |
| Filing → |
| VTYX | SELL | 2023-10-04 | $869K | — | Filing → |
| VTYX | SELL | 2023-09-07 | $977K | — | Filing → |
| VTYX | SELL | 2023-08-04 | $1.1M | — | Filing → |